GNRH1 and prostate carcinoma: In line with these observations, GnRH analogs were also reported to inhibit the growth of the rat androgen-independent Dunning R-3327-AT-1 prostate cancer [99] as well as of primary cell cultures from human prostate carcinomas [116].